Medical Weight Loss for Pierre, South Dakota Residents
Pierre, South Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Pierre through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Pierre Residents Choose New Hope Weight Loss
Pierre patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across South Dakota and beyond since 2020.
Pierre is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Pierre address.
Patients across Pierre and the surrounding area connect with Dr. Sharma by secure video, wherever they live in South Dakota. We care for patients throughout downtown Pierre, the South Dakota capital, on the Missouri River. Every prescription for Pierre is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Telehealth removes the distance between Pierre and specialized care: your consultation happens wherever you are in South Dakota. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Pierre patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Pierre
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Pierre address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Pierre
Does New Hope Weight Loss treat patients in Pierre?
Yes. Although the clinic is in Costa Mesa, California, we treat Pierre, South Dakota residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Pierre?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Pierre address in cold-pack packaging.
What do Pierre patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Pierre do you serve?
We serve patients from across Pierre by telehealth, including downtown Pierre, the South Dakota capital, on the Missouri River.
Are there hidden fees for Pierre patients?
No. Pierre patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Pierre, South Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.